(R)-2-(2-(Tert-Butoxy)-2-Oxoethyl)Pent-4-Enoic Acid置于氢气,Palladium(II) Hydroxide体系中,用 乙酸乙酯 用作溶剂,化学反应生成(R)-2-(2-乙酰叔丁酯基)-戊酸
参考文献:Cyclic Tetramer Compounds As Proprotein Convertase Subtilisin/kexin Type 9 (Pcsk9) Inhibitors For The Treatment Of Metabolic Disorders
标题:Cyclic Tetramer Compounds As Proprotein Convertase Subtilisin/kexin Type 9 (Pcsk9) Inhibitors For The Treatment Of Metabolic Disorders
摘要:该披露涉及对pcsk9的抑制剂,用于治疗胆固醇脂质代谢以及其他pcsk9发挥作用的疾病,其化学式为(I): 或其药用可接受的盐,水合物,溶剂合物,前药,立体异构体,N-氧化物或互变异构体,其中r1,R2,R3,R4,R5,R6,R7,R8,R9,X1,X2和x3如本文所述.